Skip to main content
Equibles

Caption Management, LLC

Position in GMAB — Genmab A/S

CIK 1706766 OKLAHOMA CITY, OK
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,487,791
+$1,844,306 QoQ
Shares Held
199,774
+7.4% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#44
of 292 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Derivatives in GMAB

reported options exposure · as of Jun 30, 2026
CallValue
$19,174,060
CallShares
698,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. GMAB ranks #11 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in GMAB

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,174,060 698,000
2026-06-30 $5,487,791 199,774
2025-03-31 $3,643,485 186,082
2025-03-31 $5,920,992 302,400
2025-03-31 $4,100,052 209,400
2021-06-30 $1,735,275 42,500